Prediction of overall survival in patients across solid tumors following atezolizumab treatments: A tumor growth inhibition–overall survival modeling framework

Abstract The objectives of the study were to use tumor size data from 10 phase II/III atezolizumab studies across five solid tumor types to estimate tumor growth inhibition (TGI) metrics and assess the impact of TGI metrics and baseline prognostic factors on overall survival (OS) for each tumor type...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Phyllis Chan, Mathilde Marchand, Kenta Yoshida, Shweta Vadhavkar, Nina Wang, Alyse Lin, Benjamin Wu, Marcus Ballinger, Nitzan Sternheim, Jin Y. Jin, René Bruno
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Wiley 2021-10-01
Reeks:	CPT: Pharmacometrics & Systems Pharmacology
Online toegang:	https://doi.org/10.1002/psp4.12686
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!